{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:54Z","timestamp":1772119734664,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11033-022-08198-z","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:03:39Z","timestamp":1672743819000},"page":"2445-2451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa"],"prefix":"10.1007","volume":"50","author":[{"given":"Savera","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-9484","authenticated-orcid":false,"given":"Najeeb Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Sombal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan Ullah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakif Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aqib","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqbal","family":"Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"8198_CR1","first-page":"151","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Salehiniya H (2019) Epidemiological characteristics of and risk factors for breast cancer in the world. Breast cancer (Dove Med Press 11:151\u2013164","journal-title":"Breast cancer (Dove Med Press"},{"key":"8198_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","volume":"1","author":"GN Sharma","year":"2010","unstructured":"Sharma GN, Dave R, Sanadya J, Sharma P, Sharma K (2010) Various types and management of breast cancer: an overview. J Adv Pharm Technol Res Medknow Publications 1:109","journal-title":"J Adv Pharm Technol Res Medknow Publications"},{"key":"8198_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","volume":"35","author":"M Nikolaou","year":"2018","unstructured":"Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E (2018) The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis Springer 35:309\u2013318","journal-title":"Clin Exp Metastasis Springer"},{"key":"8198_CR4","doi-asserted-by":"publisher","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L et al (2018) Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis [Internet]. Elsevier Ltd; 5:77\u2013106. Available from: https:\/\/doi.org\/10.1016\/j.gendis.2018.05.001","DOI":"10.1016\/j.gendis.2018.05.001"},{"key":"8198_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","volume":"38","author":"P Eroles","year":"2012","unstructured":"Eroles P, Bosch A, P\u00e9rez-Fidalgo JA, Lluch A (2012) Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev Elsevier 38:698\u2013707","journal-title":"Cancer Treat Rev Elsevier"},{"key":"8198_CR6","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1007\/s00018-021-03860-4","volume":"78","author":"M Rusidz\u00e9","year":"2021","unstructured":"Rusidz\u00e9 M, Adlanm\u00e9rini M, Chantalat E, Raymond-Letron I, Cayre S, Arnal J-F et al (2021) Estrogen receptor-\u03b1 signaling in post-natal mammary development and breast cancers. Cell Mol Life Sci Springer 78:5681\u20135705","journal-title":"Cell Mol Life Sci Springer"},{"key":"8198_CR7","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.3390\/ijms21207691","volume":"21","author":"E Kudela","year":"2020","unstructured":"Kudela E, Samec M, Koklesova L, Liskova A, Kubatka P, Kozubik E et al (2020) miRNA expression profiles in luminal A breast cancer\u2014implications in biology, prognosis, and prediction of response to hormonal treatment. Int J Mol Sci MDPI 21:7691","journal-title":"Int J Mol Sci MDPI"},{"key":"8198_CR8","first-page":"108","volume":"14","author":"R Garc\u00eda-Becerra","year":"2012","unstructured":"Garc\u00eda-Becerra R, Santos N, D\u00edaz L, Camacho J (2012) Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance. Int J Mol Sci Molecular Diversity Preservation International (MDPI) 14:108\u2013145","journal-title":"Int J Mol Sci Molecular Diversity Preservation International (MDPI)"},{"key":"8198_CR9","doi-asserted-by":"crossref","unstructured":"Cheng SL, Lin H-JL, Huang TH-M (2008) Interrogating estrogen receptor \u03b1 signaling in breast Cancer by chromatin immunoprecipitation microarrays. Genomics Endocrinol. Springer, pp 115\u2013129","DOI":"10.1007\/978-1-59745-309-7_6"},{"key":"8198_CR10","first-page":"e900","volume-title":"Hormone receptor\u2013positive\/human epidermal growth receptor 2\u2013negative metastatic breast cancer in young women: emerging data in the era of molecularly targeted agents","author":"AN Shah","year":"2020","unstructured":"Shah AN, Metzger O, Bartlett CH, Liu Y, Huang X, Cristofanilli M (2020) Hormone receptor\u2013positive\/human epidermal growth receptor 2\u2013negative metastatic breast cancer in young women: emerging data in the era of molecularly targeted agents, vol 25. Oxford University Press, Oncologist, pp e900\u2013e908"},{"key":"8198_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0686-1","volume":"12","author":"ZS Lima","year":"2019","unstructured":"Lima ZS, Ghadamzadeh M, Arashloo FT, Amjad G, Ebadi MR, Younesi L (2019) Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. J Hematol Oncol Springer 12:1\u201325","journal-title":"J Hematol Oncol Springer"},{"key":"8198_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mgg3.1310","volume":"8","author":"M Shah","year":"2020","unstructured":"Shah M, Danish L, Khan NU, Zaman F, Ismail M, Hussain M et al (2020) Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan. Mol Genet Genomic Med 8:1\u201310","journal-title":"Mol Genet Genomic Med"},{"key":"8198_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-019-0268-z","volume":"15","author":"F Adnan","year":"2020","unstructured":"Adnan F, Khan NU, Iqbal A, Ali I, Petruzziello A, Sabatino R et al (2020) Interleukin-6 polymorphisms in HCC patients chronically infected with HCV. Infect Agent Cancer Infectious Agents and Cancer 15:1\u20137","journal-title":"Infect Agent Cancer Infectious Agents and Cancer"},{"key":"8198_CR14","doi-asserted-by":"publisher","unstructured":"Hayat F, Khan NU, Khan AU, Ahmad I, Alamri AM, Iftikhar B (2022) Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan. PLoS One [Internet]. ;17:e0276813. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0276813","DOI":"10.1371\/journal.pone.0276813"},{"key":"8198_CR15","doi-asserted-by":"publisher","unstructured":"Jehanzeb M, Khan NU, Hussain M, Subrina J, Ayub S, Mustafa A (2022) Association of candidate genes (ALR2, RAGE, and VEGF) polymorphisms with diabetic retinopathy in type 2 diabetic patients of Khyber Pakhtunkhwa, Pakistan. Mol Biol Rep [Internet]. Springer Netherlands; Available from: https:\/\/doi.org\/10.1007\/s11033-022-08057-x","DOI":"10.1007\/s11033-022-08057-x"},{"key":"8198_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.23005","volume":"34","author":"C Jin","year":"2020","unstructured":"Jin C, Li Z, Zheng X, Shen K, Chao J, Dong Y et al (2020) Development and validation of T-ARMS-PCR to detect CYP2C19*17 allele. J Clin Lab Anal 34:1\u20135","journal-title":"J Clin Lab Anal"},{"key":"8198_CR17","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3390\/genes13111940","volume":"13","author":"MM Garbuz","year":"2022","unstructured":"Garbuz MM, Ovchinnikova AA, Kumeiko VV, Design (2022) Optimization and validation of the ARMS PCR protocol for the Rapid diagnosis of Wilson\u2019s Disease using a panel of 14 common mutations for the European Population. Genes (Basel) 13:1940","journal-title":"Genes (Basel)"},{"key":"8198_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH et al (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet Nature Publishing Group 50:1219\u20131224","journal-title":"Nat Genet Nature Publishing Group"},{"key":"8198_CR19","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1002\/jcp.27464","volume":"234","author":"M Mahdavi","year":"2019","unstructured":"Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R et al (2019) Hereditary breast cancer; genetic penetrance and current status with BRCA. J Cell Physiol Wiley Online Library 234:5741\u20135750","journal-title":"J Cell Physiol Wiley Online Library"},{"key":"8198_CR20","first-page":"1141","volume":"32","author":"R Siersb\u00e6k","year":"2018","unstructured":"Siersb\u00e6k R, Kumar S, Carroll JS (2018) Signaling pathways and steroid receptors modulating estrogen receptor \u03b1 function in breast cancer. Genes Dev Cold Spring Harbor Lab 32:1141\u20131154","journal-title":"Genes Dev Cold Spring Harbor Lab"},{"key":"8198_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R (2015) ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol 12:573\u2013583","journal-title":"Nat Rev Clin Oncol"},{"key":"8198_CR22","first-page":"1927","volume":"24","author":"DI Carrillo-Moreno","year":"2019","unstructured":"Carrillo-Moreno DI, Figuera LE, Gonz\u00e1lez GMZ, Perez AMP, Mendoza AJM, Arreola MPG (2019) Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of mexican population. J BUON 24:1927\u20131933","journal-title":"J BUON"},{"key":"8198_CR23","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.clbc.2020.10.003","volume":"21","author":"W Yang","year":"2021","unstructured":"Yang W, He X, He C, Peng L, Xing S, Li D et al (2021) Impact of ESR1 polymorphisms on risk of breast cancer in the Chinese han population. Clin Breast Cancer Elsevier 21:e235\u2013e242","journal-title":"Clin Breast Cancer Elsevier"},{"key":"8198_CR24","first-page":"927","volume":"100","author":"M Iwasaki","year":"2009","unstructured":"Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola J Jr, Laginha FM et al (2009) Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in japanese, japanese brazilians and non\u2010japanese brazilians. Cancer Sci Wiley Online Library 100:927\u2013933","journal-title":"Cancer Sci Wiley Online Library"},{"key":"8198_CR25","doi-asserted-by":"crossref","unstructured":"Mirzaeyan P, Shokrzadeh M, Salehzadeh A, Ajamian F (2020) Association of estrogen receptor 1 (ESR1) gene (rs2234693) polymorphism, ESR1 promoter methylation status, and serum heavy metals concentration, with breast cancer: a study on iranian women population. Meta gene, vol 26. Elsevier, p 100802","DOI":"10.1016\/j.mgene.2020.100802"},{"key":"8198_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10549-013-2494-1","volume":"139","author":"Z Yang","year":"2013","unstructured":"Yang Z, Shen J, Cao Z, Wang B (2013) Association between a novel polymorphism (rs2046210) of the 6q25. 1 locus and breast cancer risk. Breast Cancer Res Treat Springer 139:267\u2013275","journal-title":"Breast Cancer Res Treat Springer"},{"key":"8198_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/ng.318","volume":"41","author":"W Zheng","year":"2009","unstructured":"Zheng W, Long J, Gao Y-T, Li C, Zheng Y, Xiang Y-B et al (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25. 1. Nat Genet Nature Publishing Group 41:324\u2013328","journal-title":"Nat Genet Nature Publishing Group"},{"key":"8198_CR28","doi-asserted-by":"crossref","unstructured":"Thanh NTN, Lan NTT, Phat PT, Giang NDT, Hue NT (2018) Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a vietnamese case-control cohort.Genes Genet Syst. The Genetics Society of Japan; 17\u201353","DOI":"10.1266\/ggs.17-00053"},{"key":"8198_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1001029","volume":"6","author":"SN Stacey","year":"2010","unstructured":"Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A et al (2010) Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 6:1\u201312","journal-title":"PLoS Genet"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08198-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:11:54Z","timestamp":1728645114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08198-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["8198"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08198-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2104973\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was taken from the institute of Biotechnology and Genetic Engineering, and written consent was taken from all the participants after explaining the aim and objective of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read the article and agreed to publish the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}